PD-1 blockade by CT-011, anti PD-1 antibody, enhances ex-vivo T cell responses to autologous dendritic/myeloma fusion vaccine

類似資料

• Fusions of Dendritic Cells with Breast Carcinoma Stimulate the Expansion of Regulatory T Cells while Concomitant Exposure to IL-12, CpG Oligodeoxynucleotides, and Anti-CD3/CD28 Promotes the Expansion of Activated Tumor Reactive Cells
  著者:: Vasir, Baldev, 等
  出版事項: (2008)
• Lenalidomide enhances anti-myeloma cellular immunity
  著者:: Luptakova, Katarina, 等
  出版事項: (2012)
• Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients
  著者:: Rosenblatt, Jacalyn, 等
  出版事項: (2013)
• Generation of Tumor-specific T Lymphocytes Using Dendritic Cell/Tumor Fusions and Anti-CD3/CD28
  著者:: Rosenblatt, Jacalyn, 等
  出版事項: (2010)
• Induction of Anti-Tumor Immunity Ex Vivo Using Dendritic Cells Transduced with Fowl Pox Vector Expressing MUC1, CEA, and a Triad of Costimulatory Molecules (rF-PANVAC)()
  著者:: Vasir, Baldev, 等
  出版事項: (2012)